A detailed history of Vontobel Holding Ltd. transactions in Alector, Inc. stock. As of the latest transaction made, Vontobel Holding Ltd. holds 11,000 shares of ALEC stock, worth $21,120. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,000
Previous 11,000 -0.0%
Holding current value
$21,120
Previous $49,000 4.08%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$4.19 - $6.23 $8,380 - $12,460
-2,000 Reduced 15.38%
11,000 $49,000
Q1 2024

May 10, 2024

BUY
$5.69 - $8.08 $11,380 - $16,160
2,000 Added 18.18%
13,000 $78,000
Q3 2023

Jun 03, 2024

SELL
$5.2 - $8.77 $10,400 - $17,540
-2,000 Reduced 15.38%
11,000 $71,000
Q3 2023

Oct 10, 2023

BUY
$5.2 - $8.77 $57,200 - $96,470
11,000 New
11,000 $71,000
Q3 2021

Oct 29, 2021

BUY
$21.65 - $39.49 $43,300 - $78,980
2,000 Added 6.67%
32,000 $730,000
Q4 2020

Feb 12, 2021

BUY
$9.4 - $16.7 $282,000 - $501,000
30,000 New
30,000 $454,000

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $159M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Vontobel Holding Ltd. Portfolio

Follow Vontobel Holding Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Vontobel Holding Ltd. with notifications on news.